News tagged with platelet
Study finds protein in platelets fight malaria but only for some people
(Medical Xpress)—Researchers in Australia have found that a protein in platelets found naturally in blood has a protective effect against malaria. In their paper published in the journal Science, the team describes how th ...
Medical research
Dec 07, 2012 |
5 / 5 (1) |
0
|
Scientists discover elusive platelet count and limb development gene
Researchers have identified an elusive gene responsible for Thrombocytopenia with Absent Radii (TAR), a rare inherited blood and skeletal disorder. As a result, this research is now being transformed into ...
Genetics
Feb 26, 2012 |
5 / 5 (3) |
0
|
Cardiovascular disease linked to evolutionary changes that may have protected early mammals from trauma
(Medical Xpress) -- Can a bird have a heart attack? A recent paper published by researchers at the Perelman School of Medicine at the University of Pennsylvania suggests that cardiovascular disease may ...
Medical research
Oct 18, 2011 |
3.7 / 5 (3) |
0
|
Gene offers clues to new treatments for a harmful blood clotting disorder
(Medical Xpress)—A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis—the formation ...
Genetics
May 08, 2013 |
5 / 5 (1) |
0
|
Artificial platelets could treat injured soldiers on the battlefield
When it comes to healing the terrible wounds of war, success may hinge on the first blood clot – the one that begins forming on the battlefield right after an injury.
Medical research
Feb 15, 2013 |
4.7 / 5 (3) |
0
|
Ills of aging blood: Short-circuited stem cell programming linked to failing blood development
As blood stem cells age, changes in the epigenome—the system that regulates which genes are switched on and which are switched off throughout the body—alter these cells in ways that lead to reduced immune ...
Medical research
Feb 15, 2013 |
5 / 5 (5) |
0
|
Mystery bleeding disorders could be unraveled by new research efforts
(Medical Xpress)—Platelet disorders are heavily underdiagnosed, little understood and cannot be cured. University of Birmingham researchers and the Birmingham Platelet Group are running a UK-wide clinical trial 'Genotyping ...
Medical research
Feb 11, 2013 |
5 / 5 (1) |
0
|
Team mimicking a natural defense against malaria to develop new treatments
(Medical Xpress)—One of the world's most devastating diseases is malaria, responsible for at least a million deaths annually, despite global efforts to combat it. Researchers from the Perelman School ...
Medical research
Dec 27, 2012 |
5 / 5 (2) |
1
|
Study shows how dark chocolate may be good for our health—particularly if you are male
(Medical Xpress)—Cocoa-rich dark chocolate might help protect against heart disease and stroke, but probably more so if you are a man.
Health
Dec 24, 2012 |
5 / 5 (3) |
1
|
How does immune globulin therapy work? Now is the time to find out
Immune globulin replacement began decades ago as a treatment for patients who could not make their own protective antibodies, but has proven to have much broader benefits than originally expected. With new uses regularly ...
Immunology
Nov 21, 2012 |
5 / 5 (1) |
0
|
Some heart patients may respond differently to anti-platelet drugs
The cause of heart attacks or strokes among some patients treated with anti-platelet drugs may be different than for patients who have undergone surgical procedures to restore blood flow, according to researchers at Duke ...
Cardiology
Nov 05, 2012 |
not rated yet |
0
|
Pre-op eltrombopag reduces need for platelet transfusions
(HealthDay)—For patients with chronic liver disease who require an invasive procedure as part of their routine care, the oral thrombopoietin-receptor agonist eltrombopag reduces the need for platelet transfusions, ...
Diseases, Conditions, Syndromes
Aug 23, 2012 |
not rated yet |
0
|
Study reports validation of the first point-of-care genetic test in medicine, regarding use of antiplatelet therapy
A study published Online First by the Lancet reports the successful validation and clinical application of the first point-of-care genetic test in medicine. The test successfully identifies the CYP2C19*2 allele: a common ...
Cardiology
Mar 28, 2012 |
not rated yet |
0
|
Platelet inhibitor reduces size of large heart attacks
The anti-platelet drug abciximab, delivered directly to lesions caused by a heart attack, significantly decreased damage to the heart muscle in high-risk patients while clot aspiration showed no impact, according to research ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
New class of platelet blockers proves effective in phase III trial
Adding vorapaxar, an investigational platelet blocker, to standard antiplatelet therapy significantly reduces the risk of recurrent cardiovascular events in patients with known atherosclerosis, a hardening and narrowing of ...
Cardiology
Mar 26, 2012 |
not rated yet |
0
|
Platelet
Platelets, or thrombocytes (from Greek θρόμβος, "clot" and κύτος, "cell"), are small, irregularly shaped clear cell fragments (i.e. cells that do not have a nucleus containing DNA), 2–3 µm in diameter, which are derived from fragmentation of precursor megakaryocytes. The average lifespan of a platelet is normally just 5 to 9 days. Platelets are a natural source of growth factors. They circulate in the blood of mammals and are involved in hemostasis, leading to the formation of blood clots.
If the number of platelets is too low, excessive bleeding can occur. However, if the number of platelets is too high, blood clots can form (thrombosis), which may obstruct blood vessels and result in such events as a stroke, myocardial infarction, pulmonary embolism or the blockage of blood vessels to other parts of the body, such as the extremities of the arms or legs. An abnormality or disease of the platelets is called a thrombocytopathy, which could be either a low number of platelets (thrombocytopenia), a decrease in function of platelets (thrombasthenia), or an increase in the number of platelets (thrombocytosis). There are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) or thrombotic thrombocytopenic purpura (TTP) that typically cause thromboses, or clots, instead of bleeding.
Platelets release a multitude of growth factors including Platelet-derived growth factor (PDGF), a potent chemotactic agent, and TGF beta, which stimulates the deposition of extracellular matrix. Both of these growth factors have been shown to play a significant role in the repair and regeneration of connective tissues. Other healing-associated growth factors produced by platelets include basic fibroblast growth factor, insulin-like growth factor 1, platelet-derived epidermal growth factor, and vascular endothelial growth factor. Local application of these factors in increased concentrations through Platelet-rich plasma (PRP) has been used as an adjunct to wound healing for several decades.
For more information about Platelet, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.